HR 2620
116th Congress
House
Health
Administrative law and regulatory procedures
Congressional oversight
Department of Health and Human Services
Drug therapy
Executive agency funding and structure
Financial services and investments
Genetics
Government information and archives
Government lending and loan guarantees
Government studies and investigations
Health programs administration and funding
Health promotion and preventive care
Health technology, devices, supplies
Hearing, speech, and vision care
Interest, dividends, interest rates
Medical research
Public-private cooperation
Research administration and funding
Research and development
Faster Treatments and Cures for Eye Diseases Act
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 10, 2019
Referred to the Subcommittee on Health.
May 9, 2019
Referred to the House Committee on Energy and Commerce.
May 9, 2019
Introduced in House
Plain-English summary
Faster Treatments and Cures for Eye Diseases Act
This bill requires the Department of Health and Human Services to establish a pilot program that provides for a partial federal guarantee of specified bonds, the sale of which shall finance promising translational vision-impairment research with private investment. The Government Accountability Office must study this program and consider whether similar programs should be established for other areas of biomedical research.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2